Dr. Jacobs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3801 Miranda Ave
Palo Alto, CA 94304Phone+1 650-493-5000Fax+1 650-849-1213- Is this information wrong?
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1975 - 1977
University of California (San Francisco)Residency, Internal Medicine, 1974 - 1975
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1972 - 1974- Washington University in St. Louis School of MedicineClass of 1972
Certifications & Licensure
CA State Medical License 1974 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Fellow (FASCO) American Society of Clinical Oncologists, 2007
Clinical Trials
- A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung Cancer Start of enrollment: 2004 Apr 01
Publications & Presentations
PubMed
- 20 citationsDouble-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial o...Aarti K. Bhatia, Ju Whei Lee, Harlan A. Pinto, Charlotte Jacobs, Paul J. Limburg, Philip Rubin, Robert M. Arusell, Eamonn Patrick Dunphy, Janardan D. Khandekar, Seth A...> ;Cancer. 2017 Dec 1
- A phase I dose-escalation study of apatorsen (OGX-427), an antisense inhibitor targeting heat shock protein 27 (Hsp27), in patients with castration-resistant prostate ...Chi KN, Yu EY, Jacobs C, Bazov J, Kollmannsberger C, Higano CS, Mukherjee SD, Gleave ME, Stewart PS, Hotte SJ> ;Ann. Oncol.. 2016-06-01
- Should de-escalation of bone-targeting agents be standard of care for patients with bone metastases from breast cancer? A systematic review and meta-analysis.Ibrahim MFK, Mazzarello S, Shorr R, Vandermeer L, Jacobs C, Hilton J, Hutton B, Clemons M> ;Ann. Oncol.. 2015-11-01
- Join now to see all
Grant Support
- Bexarotene In Combination With Iressa In Treatment Of Non-Small Cell Lung CancerNational Center For Research Resources2006
- Stanford University Participation In The NCOGNational Cancer Institute1985–1986
- Day Care Center--CoreNational Cancer Institute1985
Professional Memberships
- Fellow
Hospital Affiliations
Stanford Health CarePalo Alto, California
VA Palo Alto Heath CarePalo Alto, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
